Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance

BACKGROUND: Safety and effectiveness of aflibercept with 5‐fluorouracil/levofolinate/irinotecan have not been reported in Japanese patients with metastatic colorectal cancer (mCRC) in a real-world clinical setting. METHODS: This post-marketing surveillance enrolled patients with un-resectable advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Jun, Terazawa, Tetsuji, Yamane, Shiho, Kazama, Hirotaka, Uetake, Hiroyuki, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823052/
https://www.ncbi.nlm.nih.gov/pubmed/36307632
http://dx.doi.org/10.1007/s10147-022-02259-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823052/
https://www.ncbi.nlm.nih.gov/pubmed/36307632
http://dx.doi.org/10.1007/s10147-022-02259-w

Ejemplares similares